天康制药 (874339.OC)

+ 收藏

利润表(天康制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年一季报2022年年报
上市前/上市后 上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表
一、营业总收入(元) 337,501,944.691,062,455,312.28289,629,076.98991,538,185.07
 营业收入(元) 337,501,944.691,062,455,312.28289,629,076.98991,538,185.07
二、营业总成本(元) 226,670,148.92865,609,167.45191,196,645.01761,842,586.32
 营业成本(元) 111,419,857.80394,719,333.3796,509,844.37355,584,661.15
 研发费用(元) 31,943,637.19177,087,225.0637,083,579.19137,179,449.40
 营业税金及附加(元) 3,405,361.998,917,464.253,282,194.568,000,657.72
 销售费用(元) 65,853,513.98234,239,474.1046,262,899.36209,084,416.64
 管理费用(元) 16,841,141.8971,648,444.5110,997,222.2149,813,070.45
 财务费用(元) -2,793,363.93-21,002,773.84-2,939,094.682,180,330.96
  其中:利息费用(元) 163,635.53139,436.1139,136.226,459,424.84
  其中:利息收入(元) 2,985,376.9121,189,328.973,002,792.124,459,146.98
三、其他经营收益
 加:公允价值变动收益(元) 10,591.32-3,530.44-939,452.06939,452.06
 加:投资收益(元) -3,731,159.743,659,085.043,501,912.57
 资产处置收益(元) 1,276,997.11-254,823.22--
 资产减值损失(元) -1,061,930.70-10,952,745.85-10,525,903.51-1,643,082.53
 信用减值损失(元) -11,674,850.90-15,191,240.97-10,712,080.39-22,446,604.65
 其他收益(元) 2,361,411.2611,409,597.781,066,417.394,675,549.52
四、营业利润(元) 101,744,013.86185,584,561.8780,980,498.44214,722,825.72
 加:营业外收入(元) 12,601.11765,751.46144,463.32215,604.72
 减:营业外支出(元) 281,434.823,539,723.293,124,090.12256,746.88
五、利润总额(元) 101,475,180.15182,810,590.0478,000,871.64214,681,683.56
 减:所得税费用(元) 16,964,756.8515,338,114.2412,455,234.1916,757,397.25
六、净利润(元) 84,510,423.30167,472,475.8065,545,637.45197,924,286.31
(一)按经营持续性分类
  持续经营净利润(元) 84,510,423.30167,472,475.8065,545,637.45197,924,286.31
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 84,777,288.51169,033,729.4266,467,595.52199,194,390.58
  少数股东损益(元) -266,865.21-1,561,253.62-921,958.07-1,270,104.27
 扣除非经常性损益后的净利润(元) 82,418,825.02159,720,087.5165,391,100.00190,523,800.00
七、每股收益
 一、基本每股收益(元) 0.330.660.26-
 二、稀释每股收益(元) 0.330.660.26-
九、综合收益总额(元) 84,510,423.30167,472,475.8065,545,637.45197,924,286.31
 归属于母公司所有者的综合收益总额(元) 84,777,288.51169,033,729.4266,467,595.52199,194,390.58
 归属于少数股东的综合收益总额(元) -266,865.21-1,561,253.62-921,958.07-1,270,104.27
公告日期 2024-04-292024-04-262023-09-272023-09-27
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院